Improved bioavailability of buccal nanoemulsion vitamin D compared to conventional oral supplementation in patients with inflammatory bowel disease: a randomized controlled trial
In IBD patients, the sufficient supplementation dose of the orally absorbable cholecalciferol is half that of the conventional oil emulsion (1143 IU/day vs. 2000 IU/day). Variable intestinal absorption is not a factor explaining inter-individual differences in 25OHD levels using a conventional vitamin D emulsion.
Authors
- Vladimír Kojecký
- Josef Klhůfek (ORCID: https://orcid.org/0000-0001-8331-2525)
- Bohuslav Kianička (ORCID: https://orcid.org/0000-0003-0988-5928)
- Pavel Kohout (ORCID: https://orcid.org/0000-0002-3957-7005)
Institutions
- Tomas Bata University in Zlín (CZ)
- Charles University (CZ)
- Masaryk University (CZ)
- St. Anne's University Hospital Brno (CZ)
- Thomayer University Hospital (CZ)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-08-25
- DOI
- https://doi.org/10.3389/fmed.2025.1649677
- Citations
- 1
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47